Synthesis and Preliminary In vitro Investigation of Bivalent Ligands Containing Homo- and Heterodimeric Pharmacophores at μ, δ, and κ Opioid Receptors
- 3 December 2005
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (1) , 256-262
- https://doi.org/10.1021/jm050577x
Abstract
A series of homo- and heterodimeric ligands containing kappa agonist and mu agonist/antagonist pharmacophores joined by a linker chain of varying lengths was synthesized and evaluated in vitro by their binding affinity at mu, delta, and kappa opioid receptors. The functional activities of these compounds were measured in the [(35)S]GTPgammaS binding assay. The data suggest that the stereochemistry of the pharmacophores, the N-substituents of the pharmacophore, ester linkages, and the spacer length were crucial factors for optimum interactions of such ligands at opioid receptor binding sites. These novel ligands as well as their pharmacological properties will serve as the basis for our continuing investigation of such bivalent ligands as probes of the opioid receptor oligomerization phenomena and for in vivo studies as analgesics.Keywords
This publication has 13 references indexed in Scilit:
- A Bivalent Ligand (KDAN-18) Containing δ-Antagonist and κ-Agonist Pharmacophores Bridges δ2 and κ1 Opioid Receptor PhenotypesJournal of Medicinal Chemistry, 2004
- Design and Synthesis of Novel Dimeric Morphinan Ligands for κ and μ Opioid ReceptorsJournal of Medicinal Chemistry, 2003
- Mixed κ agonists and μ agonists/Antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinanBioorganic & Medicinal Chemistry Letters, 2001
- Dimerization of the δ Opioid Receptor:Journal of Biological Chemistry, 1997
- 7-Aminoquinolines. A novel class of agents active against herpes virusesJournal of Medicinal Chemistry, 1988
- Synthesis and biological activity of analogs of .beta.-chlornaltrexamine and .beta.-funaltrexamine at opioid receptorsJournal of Medicinal Chemistry, 1986
- Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptorsJournal of Medicinal Chemistry, 1985
- Opioid agonist and antagonist bivalent ligands as receptor probesLife Sciences, 1982
- Narcotic antagonistic potency of bivalent ligands which contain .beta.-naltrexamine. Evidence for simultaneous occupation of proximal recognition sitesJournal of Medicinal Chemistry, 1982
- Carbonation of Aqueous Solutions with Acid AnhydridesJournal of Pharmaceutical Sciences, 1965